Latest filing published 26 Aug 2015 for Neurogene Inc., €55k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -40.0%Entry US$344.80 · Close at T+365 US$206.80
- -53.2%Entry US$414.00 · Close at T+365 US$193.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Chilton Mitchell: trading record in brief
All filings by David Chilton Mitchell on record concern Neurogene Inc. Over a trading history stretching from 11 August 2015 to 24 August 2015, the count stands at 2 filings.
The open-market record is one-sided, with 2 purchases worth €90k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 26 August 2015: an open-market purchase of €55k, in Neurogene Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Chilton Mitchell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,575 shares@ US$17.81Common StockSEC:0001209191-15-068028:0Canonical exit: 22 Nov 2015 (T+90)
- 1,600 shares@ US$24.36Common StockSEC:0001209191-15-065926:0Canonical exit: 9 Nov 2015 (T+90)
2 of 2 declarations